The capstone, stated plainly: getting started = getting informed. The recommended path runs concepts → mechanism → risk → evidence-reading → context, and it never arrives at a dose by design. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706 Where studies used schedules, that lives in Protocols as referenced research, not as a starting point. Self-experimentation is worth understanding as a concept and a cautionary tale — informal self-testing is so confounded that the self-blinding study exists precisely to do better. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 An informed decision not to proceed is a complete success. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Respecting that outcome is the ethic of the whole cluster. [4] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
Education-only. Not medical, dosing, sourcing, or legal advice. This is a reading order, not a protocol.
A path to understanding, not to a first dose. The absence of any starting instruction is deliberate.
Not an instruction guide. This cluster gives no dose, protocol, schedule, sourcing, legal clearance, or medical advice — only the concepts, risks, evidence limits, and questions to understand before any decision, including the decision not to proceed.
The recommended reading order
The library is built to be read in an order that moves from understanding to evaluation — never toward action.
| Step | Read | Why here |
|---|---|---|
| 1 | What a microdose is and how the field is studied | Concepts before everything |
| 2 | How It Works | What the compound does, mechanism vs result |
| 3 | Safety and Interactions | Risk before evidence of benefit |
| 4 | How to evaluate what you read | The tools to judge claims |
| 5 | Research literature and Use Cases | Specific claims, now readable |
By the time you reach claims about specific uses, you can weigh them — which is the entire purpose of the sequence. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Why research-first, and why no protocol
“Research-first” names the posture exactly: the starting point is understanding the evidence, not beginning a practice. That is why no starting dose or schedule appears anywhere in this cluster — a protocol would convert orientation into instruction and make this an on-ramp to use, which it deliberately is not. Where studies used particular schedules, the Protocols material describes them as referenced research: what studies did, never your starting point. The absence is the design.
Self-experimentation, understood not recommended
Self-experimentation is a genuine research-literacy concept, but as a personal method it is deeply confounded: without blinding you cannot separate the compound from your own expectations. The self-blinding study exists precisely because informal self-testing is so unreliable. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 Understand it as a concept and a cautionary tale — reliable answers come from controlled research, not an n-of-one.
Respecting the decision not to proceed
If you finish informed and decide against microdosing, the cluster has done its job. Getting started meant getting informed, and an informed no is a complete success, not a dead end. [4] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 The whole ethic here is that the goal was never to get you to start — only to get you informed, and to respect whatever you then decide.
Getting informed has stopping points
This path does not assume the reader continues toward use. At any point — if the evidence does not match expectations, if medications or psychiatric, cardiac, pregnancy, or seizure history introduce risk, if legal status is unclear, or if the uncertainty is simply unacceptable — the informed conclusion may be to stop. That is not a failure of the process; it is one of the reasons the process exists. Reading educational material cannot evaluate personal medical history, medication interactions, or legal exposure, so when those factors are present the next step is not another article but clinician review.
- Informed, not initiated
- The deliverable is understanding and a sound decision. [1] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
- No protocol by design
- No starting dose or schedule appears, anywhere, on purpose.
- Self-testing misleads
- Informal self-experimentation is too confounded to trust. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
- A valid no
- An informed decision not to proceed is a complete success. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Frequently asked questions
What is the recommended order to read through the library?
Start with what a microdose is and how the field is studied in Foundations, then how the compound works in How It Works, then the safety and interactions material, then the research-literacy articles on reading claims and setting expectations, and only then the use-case and other context clusters. The order moves from concepts to mechanism to risk to evidence-reading, so that by the time you reach claims about specific uses you can evaluate them. It deliberately never arrives at a dose.
Why call it research-first rather than just a beginner's guide?
Because research-first names the posture exactly: the starting point is understanding the evidence, not beginning a practice. A beginner’s guide implies a beginning; this is a guide to becoming informed. The phrase also captures the order of operations — read the research and learn to read it well before forming any view — which is the opposite of the marketing-first path most newcomers stumble into.
Why isn't there a protocol or starting dose anywhere in this cluster?
By design. A protocol or starting dose would turn orientation into instruction and make this an on-ramp to use, which it deliberately is not. The cluster’s job is to help you understand the topic and decide, not to walk you toward a first dose. Where studies used particular schedules, that is described in the Protocols material as referenced research — what studies did, never as your starting point. The absence is the point, not an oversight.
Isn't self-experimentation a reasonable way to find out for myself?
Self-experimentation is a real research-literacy concept, but as a personal method it is deeply confounded: without blinding you cannot separate the drug from your expectations, and the self-blinding study exists precisely because informal self-testing is so unreliable. [2] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 So it is worth understanding as a concept and as a cautionary tale about why personal trials mislead — not as a recommended way to settle the question. The reliable answers come from controlled research, not from an n-of-one.
If I finish all this and decide not to microdose, what was the point?
The point was the decision itself, made well. Getting started here means getting informed, and an informed decision not to proceed is a complete success, not a dead end. You will have understood the evidence, the risks, and the open questions, and reached a conclusion you can stand behind. Respecting that outcome — for yourself and for others — is the whole ethic of the cluster: the goal was never to get you to start, only to get you informed.